Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905718-21-000728
Filing Date
2021-05-24
Accepted
2021-05-24 09:34:35
Documents
2
Group Members
ABINGWORTH BIOVENTURES 8 LP

Document Format Files

Seq Description Document Type Size
1 SC 13D vera_13dmay182021.htm SC 13D 63319
2 JOINT FILING AGREEMENT vera_13dmay182021ex1.htm EX-1 3749
  Complete submission text file 0000905718-21-000728.txt   68583
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

EIN.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Subject) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92556 | Film No.: 21951574
SIC: 2834 Pharmaceutical Preparations